Pharmaceutical company.
Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs;
Issues related to CMS rule "Medicare Coverage of Innovative Technology (MCIT)" and definition of "reasonable and necessary";
Drug pricing and access, and Medicare and Medicaid reimbursement Issues related to coverage of Alzheimer's drugs and diagnostics under Federal health care programs;
Drug pricing and access, and Medicare and Medicaid reimbursement;
Issues related to pharmaceutical industry, generally
MMM - Medicare/Medicaid PHA - Pharmacy
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
RICCHETTI INCORPORATED
601 13th Street, NW, Suite 630N, Washington, DC, 20005, US
JEFF RICCHETTI JEFF RICCHETTI